BA
DXCM icon

Bristlecone Advisors’s DexCom DXCM Stock Holding History

Bristlecone Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,200
Closed -$249K – 368
2024
Q2 		$249K Hold
2,200
– – 0.02% 249
2024
Q1 		$305K Hold
2,200
– – 0.03% 228
2023
Q4 		$273K Sell
2,200
-152
-6% -$15.5K 0.03% 238
2023
Q3 		$219K Sell
2,352
-48
-2% -$5.41K 0.02% 247
2023
Q2 		$308K Buy
2,400
+48
+2% +$5.8K 0.03% 216
2023
Q1 		$273K Hold
2,352
– – 0.03% 221
2022
Q4 		$266K Buy
+2,352
New +$258K 0.03% 221

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bristlecone Advisors's DXCM Position: Q3 2024 in Review

Bristlecone Advisors sold out of DexCom (DXCM) in Q3 2024, closing a stake of 2,200 shares — an estimated $249K sold.

Bristlecone Advisors first reported a position in DXCM in Q4 2022 and held it in 7 quarters. The position peaked at $308K in Q2 2023. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Bristlecone Advisors reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Bristlecone Advisors sold 2,200 DexCom shares in Q3 2024, an estimated $249K.
  • Bristlecone Advisors first reported a position in DexCom in Q4 2022 and held it in 7 quarters.
  • Bristlecone Advisors's DexCom position peaked at $308K in Q2 2023.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Bristlecone Advisors's 13F filing for Q3 2024, filed 24 Oct 2024.